NFKB1 and myeloid sarcoma: On one hand, blocking one or several cytokines for the treatment of MS is usually insufficient considering the complex nature of this disease; on the other hand, blocking certain signaling pathways, such as the NF-κB pathway, might cause severe complications given that these signaling pathways are vital for maintaining normal cellular functions.